| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.051 | 0.08 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.08 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |